These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27916718)

  • 1. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
    Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
    Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
    Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
    Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
    Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opa interacting protein 5 acts as an oncogene in bladder cancer.
    He X; Hou J; Ping J; Wen D; He J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
    Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
    Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
    Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C
    Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
    Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
    Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
    He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
    Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
    Xu Z; Huang B; Zhang Q; He X; Wei H; Zhang D
    J Cell Biochem; 2019 Apr; 120(4):6596-6604. PubMed ID: 30426533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers.
    Chun HK; Chung KS; Kim HC; Kang JE; Kang MA; Kim JT; Choi EH; Jung KE; Kim MH; Song EY; Kim SY; Won M; Lee HG
    BMB Rep; 2010 May; 43(5):349-54. PubMed ID: 20510019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.
    He X; Ding X; Wen D; Hou J; Ping J; He J
    Pathol Res Pract; 2017 Sep; 213(9):1059-1066. PubMed ID: 28843748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opa-Interacting Protein 5 Expression in Human Glioma Tissues Is Essential to the Biological Function of U251 Human Malignant Glioma Cells.
    Chen L; Wang R; Gao L; Shi W
    Cancer Control; 2020; 27(1):1073274820968914. PubMed ID: 33153318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR.
    Kim J; Abdelmohsen K; Yang X; De S; Grammatikakis I; Noh JH; Gorospe M
    Nucleic Acids Res; 2016 Mar; 44(5):2378-92. PubMed ID: 26819413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype.
    Tommasi S; Pinto R; Danza K; Pilato B; Palumbo O; Micale L; De Summa S
    Oncotarget; 2016 Dec; 7(49):80363-80372. PubMed ID: 27385001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
    Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
    Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis.
    Wang H; Xiao Y; Wu L; Ma D
    Int J Oncol; 2018 Mar; 52(3):743-754. PubMed ID: 29431182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway.
    Hu GW; Wu L; Kuang W; Chen Y; Zhu XG; Guo H; Lang HL
    Gene; 2017 Apr; 610():24-31. PubMed ID: 28189759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
    Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
    Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.